Home>Nitrosamine and Azido Risk Assessment for Pharmaceutical Products

Nitrosamine and Azido Impurity Risk Assessment in Pharmaceutical Product

ISPE Malaysia Affiliate is delighted to invite you to tune into our upcoming webinar on the topic:

Nitrosamine and Azido Impurity Risk Assessment in pharmaceutical product.

This webinar provides an overview of the risk of Nitrosamines and Azido impurities in pharmaceutical manufacturing industries and how the pharmaceutical manufacturers could identify the risk of these unwanted impurities and establish the control measures to ensure the pharmaceutical product quality and safety to the patients.

Learning objective:

  • To understand what are Nitrosamine and Azido impurities
  • To understand how to identify the risk of Nitrosamine and Azido impurities during the manufacturing processes.
  • To learn how to establish the control measures to ensure the pharmaceutical product quality and safety to the patients.

The details for the webinar are:
Date: 24 May 2022 (Tuesday)
TIme: 9.00 AM – 1.00 PM
Platform: Zoom

For enquiries: https://ispemalaysia.org/contact-us/

Register